{"id":"https://openalex.org/W2886814879","doi":"https://doi.org/10.18632/oncotarget.25803","title":"Palbociclib resistance confers dependence on an FGFR-MAP kinase-mTOR-driven pathway inKRAS-mutant non-small cell lung cancer","display_name":"Palbociclib resistance confers dependence on an FGFR-MAP kinase-mTOR-driven pathway inKRAS-mutant non-small cell lung cancer","publication_year":2018,"publication_date":"2018-08-03","ids":{"openalex":"https://openalex.org/W2886814879","doi":"https://doi.org/10.18632/oncotarget.25803","mag":"2886814879","pmid":"https://pubmed.ncbi.nlm.nih.gov/30167080","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6114982"},"language":"en","primary_location":{"id":"doi:10.18632/oncotarget.25803","doi":"https://doi.org/10.18632/oncotarget.25803","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncotarget.25803","pdf_url":"http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=25803&path%5B%5D=80696","source":{"id":"https://openalex.org/S126644158","display_name":"Oncotarget","issn_l":"1949-2553","issn":["1949-2553"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=25803&path%5B%5D=80696","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017553205","display_name":"Eric Haines","orcid":"https://orcid.org/0000-0002-9078-0156","observed_orcids":["https://orcid.org/0000-0002-9078-0156"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Haines","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100443212","display_name":"Ting Chen","orcid":"https://orcid.org/0000-0003-1725-7956","observed_orcids":["https://orcid.org/0000-0003-1725-7956"]},"institutions":[{"id":"https://openalex.org/I4210086933","display_name":"NYU Langone Health","ror":"https://ror.org/005dvqh91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4390039310","display_name":"NYU Langone\u2019s Laura and Isaac Perlmutter Cancer Center","ror":"https://ror.org/00sa8g751","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933","https://openalex.org/I4390039310"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ting Chen","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA","Perlmutter Cancer Center, New York University, Langone Medical Center, New York, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Perlmutter Cancer Center, New York University, Langone Medical Center, New York, New York, USA","institution_ids":["https://openalex.org/I4210086933","https://openalex.org/I4390039310"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045318067","display_name":"Naveen Kommajosyula","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Naveen Kommajosyula","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100352002","display_name":"Zhao Chen","orcid":"https://orcid.org/0000-0002-5782-3329","observed_orcids":["https://orcid.org/0000-0002-5782-3329"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhao Chen","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA","Novartis Institutes for BioMedical Research, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Novartis Institutes for BioMedical Research, Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001582153","display_name":"Grit Sophie Herter-Sprie","orcid":"https://orcid.org/0000-0002-1910-9415","observed_orcids":["https://orcid.org/0000-0002-1910-9415"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210153755","display_name":"University Hospital Cologne","ror":"https://ror.org/05mxhda18","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210153755"]}],"countries":["DE","US"],"is_corresponding":false,"raw_author_name":"Grit S. Herter-Sprie","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA","University Hospital of Cologne, Weyertal, Cologne, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"University Hospital of Cologne, Weyertal, Cologne, Germany","institution_ids":["https://openalex.org/I4210153755"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109087176","display_name":"Liam Cornell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210153755","display_name":"University Hospital Cologne","ror":"https://ror.org/05mxhda18","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210153755"]}],"countries":["DE","US"],"is_corresponding":false,"raw_author_name":"Liam Cornell","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA","University Hospital of Cologne, Weyertal, Cologne, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"University Hospital of Cologne, Weyertal, Cologne, Germany","institution_ids":["https://openalex.org/I4210153755"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019034689","display_name":"Kwok\u2010Kin Wong","orcid":"https://orcid.org/0000-0001-6323-235X","observed_orcids":["https://orcid.org/0000-0001-6323-235X"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210086933","display_name":"NYU Langone Health","ror":"https://ror.org/005dvqh91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4390039310","display_name":"NYU Langone\u2019s Laura and Isaac Perlmutter Cancer Center","ror":"https://ror.org/00sa8g751","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933","https://openalex.org/I4390039310"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kwok-Kin Wong","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA","Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA","Perlmutter Cancer Center, New York University, Langone Medical Center, New York, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]},{"raw_affiliation_string":"Perlmutter Cancer Center, New York University, Langone Medical Center, New York, New York, USA","institution_ids":["https://openalex.org/I4210086933","https://openalex.org/I4390039310"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045419282","display_name":"Geoffrey Ira Shapiro","orcid":"https://orcid.org/0000-0002-3331-4095","observed_orcids":["https://orcid.org/0000-0002-3331-4095"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Geoffrey I. Shapiro","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA","Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA","Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA & Department of Medicine, Brigham and Women?s Hospital and Harvard Medical School, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]},{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA & Department of Medicine, Brigham and Women?s Hospital and Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210161994"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5045419282"],"corresponding_institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210161994"],"apc_list":null,"apc_paid":null,"fwci":5.1644,"has_fulltext":true,"cited_by_count":54,"citation_normalized_percentile":{"value":0.96577791,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"9","issue":"60","first_page":"31572","last_page":"31589"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9779999852180481,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9779999852180481,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.014700000174343586,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/palbociclib-resistance","display_name":"palbociclib resistance","score":0.9760000109672546},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.8960000276565552},{"id":"https://openalex.org/keywords/kras-mutant-non-small-cell-lung-cancer","display_name":"KRAS-mutant non-small cell lung cancer","score":0.9710000157356262},{"id":"https://openalex.org/keywords/fgfr1-signaling","display_name":"FGFR1 signaling","score":0.9020000100135803},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.6909999847412109},{"id":"https://openalex.org/keywords/mtor","display_name":"mTOR","score":0.7360000014305115},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.7829999923706055},{"id":"https://openalex.org/keywords/erk1-2","display_name":"ERK1/2","score":0.7929999828338623},{"id":"https://openalex.org/keywords/cdk6","display_name":"CDK6","score":0.9520000219345093},{"id":"https://openalex.org/keywords/d-type-cyclins","display_name":"D-type cyclins","score":0.9340000152587891},{"id":"https://openalex.org/keywords/cyclin-e","display_name":"cyclin E","score":0.9919999837875366},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.8659999966621399},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6740000247955322},{"id":"https://openalex.org/keywords/fgf-ligands","display_name":"FGF ligands","score":0.6850000023841858},{"id":"https://openalex.org/keywords/genetically-engineered-mouse-models","display_name":"genetically engineered mouse models","score":0.8460000157356262},{"id":"https://openalex.org/keywords/cell-cycle","display_name":"cell cycle","score":0.5870000123977661}],"concepts":[{"id":"https://openalex.org/C2779744173","wikidata":"https://www.wikidata.org/wiki/Q15269707","display_name":"Palbociclib","level":5,"score":0.9326132535934448},{"id":"https://openalex.org/C199649820","wikidata":"https://www.wikidata.org/wiki/Q14911762","display_name":"Cyclin-dependent kinase 6","level":5,"score":0.8210977911949158},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6237066388130188},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.599911630153656},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.576732873916626},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.5605674982070923},{"id":"https://openalex.org/C2776087337","wikidata":"https://www.wikidata.org/wiki/Q7448840","display_name":"Selumetinib","level":5,"score":0.5492553114891052},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.5475179553031921},{"id":"https://openalex.org/C51853150","wikidata":"https://www.wikidata.org/wiki/Q14911754","display_name":"Cyclin-dependent kinase 4","level":5,"score":0.5426296591758728},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.5390225648880005},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.4786185622215271},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3654259443283081},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3161494731903076},{"id":"https://openalex.org/C82495950","wikidata":"https://www.wikidata.org/wiki/Q14911732","display_name":"Cyclin-dependent kinase 2","level":4,"score":0.2728915214538574},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.27077144384384155},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.26394277811050415},{"id":"https://openalex.org/C137361374","wikidata":"https://www.wikidata.org/wiki/Q6714442","display_name":"MAP kinase kinase kinase","level":4,"score":0.2323533594608307},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.22629883885383606},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.088767409324646},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.064782053232193},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.06275516748428345},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.05591884255409241}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.18632/oncotarget.25803","doi":"https://doi.org/10.18632/oncotarget.25803","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncotarget.25803","pdf_url":"http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=25803&path%5B%5D=80696","source":{"id":"https://openalex.org/S126644158","display_name":"Oncotarget","issn_l":"1949-2553","issn":["1949-2553"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5065586","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC6114982","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6114982","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6114982","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"Text"},{"id":"pmid:30167080","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30167080","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.18632/oncotarget.25803","doi":"https://doi.org/10.18632/oncotarget.25803","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncotarget.25803","pdf_url":"http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=25803&path%5B%5D=80696","source":{"id":"https://openalex.org/S126644158","display_name":"Oncotarget","issn_l":"1949-2553","issn":["1949-2553"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4752445381","display_name":"Dana-Farber/Harvard Cancer Center SPORE in Lung Cancer","funder_award_id":"P50CA090578","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5758242661","display_name":"SPORE in Lung Cancer","funder_award_id":"P20CA090578","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G6586715722","display_name":null,"funder_award_id":"HE 6897/1-1","funder_id":"https://openalex.org/F4320320879","funder_display_name":"Deutsche Forschungsgemeinschaft"}],"funders":[{"id":"https://openalex.org/F4320310151","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86"},{"id":"https://openalex.org/F4320310274","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116"},{"id":"https://openalex.org/F4320320879","display_name":"Deutsche Forschungsgemeinschaft","ror":"https://ror.org/018mejw64"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2886814879.pdf","grobid_xml":"https://content.openalex.org/works/W2886814879.grobid-xml"},"referenced_works_count":50,"referenced_works":["https://openalex.org/W1521732454","https://openalex.org/W1833796513","https://openalex.org/W1867768655","https://openalex.org/W1874582198","https://openalex.org/W1967902354","https://openalex.org/W1977431691","https://openalex.org/W1977702358","https://openalex.org/W1988043615","https://openalex.org/W1989169445","https://openalex.org/W1991874467","https://openalex.org/W1998280666","https://openalex.org/W2010685617","https://openalex.org/W2070011883","https://openalex.org/W2088564934","https://openalex.org/W2098203835","https://openalex.org/W2103098489","https://openalex.org/W2118874870","https://openalex.org/W2120203403","https://openalex.org/W2121389354","https://openalex.org/W2121619780","https://openalex.org/W2121791757","https://openalex.org/W2127150495","https://openalex.org/W2127365222","https://openalex.org/W2129662907","https://openalex.org/W2134964552","https://openalex.org/W2144708319","https://openalex.org/W2151529122","https://openalex.org/W2154626333","https://openalex.org/W2178424952","https://openalex.org/W2219817965","https://openalex.org/W2223833389","https://openalex.org/W2299045691","https://openalex.org/W2309969893","https://openalex.org/W2341157401","https://openalex.org/W2345781825","https://openalex.org/W2346079527","https://openalex.org/W2402797587","https://openalex.org/W2474854223","https://openalex.org/W2501247313","https://openalex.org/W2520255934","https://openalex.org/W2530482928","https://openalex.org/W2537675006","https://openalex.org/W2613467753","https://openalex.org/W2748768502","https://openalex.org/W2754379784","https://openalex.org/W2771397989","https://openalex.org/W2784192277","https://openalex.org/W2793856923","https://openalex.org/W2794087772","https://openalex.org/W2806684561"],"related_works":["https://openalex.org/W2885264053","https://openalex.org/W2223833389","https://openalex.org/W2753498194","https://openalex.org/W2886185950","https://openalex.org/W4388024362","https://openalex.org/W3208502884","https://openalex.org/W3092309993","https://openalex.org/W4362594009","https://openalex.org/W4402521870","https://openalex.org/W4415942105"],"abstract_inverted_index":{"//":[0],"Eric":[1],"Haines":[2],"1":[3,11,24,34],",":[4,8,12,16,21,25],"Ting":[5],"Chen":[6,14],"1,3":[7],"Naveen":[9],"Kommajosyula":[10],"Zhao":[13],"1,4":[15],"Grit":[17],"S.":[18],"Herter-Sprie":[19],"1,5":[20],"Liam":[22],"Cornell":[23],"Kwok-Kin":[26],"Wong":[27],"1,2,3":[28],"and":[29,50,53,167,177,181,190,244,255,273,279],"Geoffrey":[30,93],"I.":[31,94],"Shapiro":[32],"1,2":[33],"Department":[35,46],"of":[36,47,86,163,192,217,224,239,271],"Medical":[37,55,68],"Oncology,":[38],"Dana-Farber":[39],"Cancer":[40,62],"Institute,":[41],"Boston,":[42,57],"MA,":[43,58,81],"USA":[44,59,73,82],"2":[45],"Medicine,":[48],"Brigham":[49],"Women\u2019s":[51],"Hospital":[52,85],"Harvard":[54],"School,":[56],"3":[60],"Perlmutter":[61],"Center,":[63,69],"New":[64,70],"York":[65],"University,":[66],"Langone":[67],"York,":[71],"NY,":[72],"4":[74],"Novartis":[75],"Institutes":[76],"for":[77],"BioMedical":[78],"Research,":[79],"Cambridge,":[80],"5":[83],"University":[84],"Cologne,":[87,89],"Weyertal,":[88],"Germany":[90],"Correspondence":[91],"to:":[92],"Shapiro,":[95],"email:":[96],"geoffrey_shapiro@dfci.harvard.edu":[97],"Keywords":[98],":":[99],"CDK4/6":[100,152,282],"inhibitor;":[101,103],"MEK":[102,180,185,256],"FGFR1;":[104],"KRAS-mutant":[105],"non-small":[106,134],"cell":[107,135,145,193,240],"lung":[108,136],"cancer;":[109],"drug":[110],"resistance":[111,158,235,249,278],"Received:":[112],"September":[113],"03,":[114,122],"2017":[115],"Accepted:":[116],"July":[117],"08,":[118],"2018":[119,123],"Published:":[120],"August":[121],"Abstract":[124],"CDK4":[125],"is":[126],"emerging":[127],"as":[128],"a":[129],"target":[130],"in":[131,206,268],"KRAS":[132,142,225],"-mutant":[133,143,226],"cancer":[137],"(NSCLC).":[138],"We":[139],"demonstrate":[140],"that":[141,275,281],"NSCLC":[144,227],"lines":[146],"are":[147],"initially":[148,228],"sensitive":[149,229],"to":[150,179,230,285],"the":[151,188,214],"inhibitor":[153,257],"palbociclib,":[154],"but":[155],"readily":[156],"acquire":[157],"associated":[159],"with":[160,236,252],"increased":[161,174,237,269],"expression":[162,189,238,270],"CDK6,":[164],"D-type":[165],"cyclins":[166],"cyclin":[168],"E.":[169],"Resistant":[170],"cells":[171],"also":[172],"demonstrated":[173],"ERK1/2":[175,243],"activity":[176,191],"sensitivity":[178],"ERK":[182,202],"inhibitors.":[183],"Moreover,":[184],"inhibition":[186,283],"reduced":[187],"cycle":[194,241],"proteins":[195],"mediating":[196],"palbociclib":[197,231,254,277],"resistance.":[198],"In":[199,246],"resistant":[200],"cells,":[201],"activated":[203],"mTOR,":[204],"driven":[205],"part":[207],"by":[208],"upstream":[209],"FGFR1":[210],"signaling":[211],"resulting":[212,267],"from":[213],"extracellular":[215],"secretion":[216],"FGF":[218],"ligands.":[219],"A":[220],"genetically-engineered":[221],"mouse":[222],"model":[223],"similarly":[232],"developed":[233],"acquired":[234],"mediators,":[242],"FGFR1.":[245],"this":[247],"model,":[248],"was":[250],"delayed":[251],"combined":[253],"treatment.":[258],"These":[259],"findings":[260],"implicate":[261],"an":[262],"FGFR1\u2013MAP":[263],"kinase\u2013":[264],"mTOR":[265],"pathway":[266],"D-cyclins":[272],"CDK6":[274],"confers":[276],"indicate":[280],"acts":[284],"promote":[286],"MAP":[287],"kinase":[288],"dependence.":[289]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2018-08-22T00:00:00"}
